Off-the-Shelf Immunotherapy Demonstrates Multipronged Attack Against Cancer
UCLA researchers have developed a new “off-the-shelf” cell therapy that shows promise for treating renal cell carcinoma (RCC), the most common type of kidney cancer. The therapy uses stem cell–derived, […]






